Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Netherlands Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20035
20044
20054
20069
20071
20083
20093
20102
20123
20133
20144
20161
20172
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S25
Takeda8
AstraZeneca6
Eli Lilly and Company2
Bayer1
Diamyd Medical AB1
Diamyd Therapeutics AB1
GlaxoSmithKline1
Ixaka Ltd1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus53
Diabetes Mellitus, Type 239
Diabetes Mellitus, Type 112
Glucose Metabolism Disorders9
Dyslipidemias8
Cardiovascular Diseases2
Metabolic Diseases2
Albuminuria1
Autoimmune Diseases1
Cataract1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.